Biofeedback of Glucose in Non-diabetic Participants
1 other identifier
interventional
50
1 country
1
Brief Summary
This research examines whether biofeedback of glucose (i.e., knowledge of one's own glucose levels) in non-diabetic participants affects their health behaviours (e.g., eating, nutrition, exercise, etc.). This study utilizes wearable continuous glucose (CGM) technology, which provides personalized feedback to participants to allow them to self-monitor their own glucose levels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 16, 2019
CompletedFirst Submitted
Initial submission to the registry
August 29, 2019
CompletedFirst Posted
Study publicly available on registry
September 4, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2019
CompletedNovember 17, 2020
September 1, 2019
5 months
August 29, 2019
November 14, 2020
Conditions
Outcome Measures
Primary Outcomes (10)
Weight in kg
Weight in kg
2 weeks
Body Mass Index (BMI)
Height in cm and weight in kg will be used to calculate BMI
2 weeks
Body fat %
Using a smart scale
2 weeks
Resting heart rate
Using a sphygmomanometer with heart rate sensor
2 weeks
Resting blood pressure (systolic and diastolic)
Using a sphygmomanometer
2 weeks
Self-reported positive and negative affect
Positive and Negative Affect Schedule (PANAS; Watson et al., 1988). The scale consists of 20 items (10 for Positive Affect; 10 for Negative Affect), with each item rated on a 5-point scale of 1 (not at all) to 5 (extremely). Items are summed for Positive affect and Negative affect, with higher scores indicating a higher level of affect in each respective scale.
2 weeks
Self-reported general health
12-Item Short-Form Health Survey (SF-12; Ware et al., 1996). The scale measures overall general self-reported physical and mental health using 12 items, on 2 to 6-point ordinal scales. The range of possible total scores is 12 to 48, with higher scores indicating better health.
2 weeks
Self-reported perceived stress
Perceived Stress Scale (Cohen et al., 1983; Cohen \& Williamson, 1988). This is a 4-item scale that measures overall stress with each item evaluated on a 5-point Likert scale. The range of possible total scores is 0 to 16, with higher scores indicating more stress.
2 weeks
Self-reported sleep quality
Pittsburgh Sleep Quality Index (Buysse et al., 1989). This is a 19-item scale that measures self-reported sleep quality and sleep disturbances, comprised of open-ended questions and scaled items evaluated on a 4-point Likert scale. The range of possible total scores is 0 to 21, with higher scores indicating poorer sleep quality.
2 weeks
Self-reported general well-being
Satisfaction with Life Scale (Diener et al., 1985). This is a 5-item scale that measures overall well-being with each item evaluated on a 7-point Likert scale. The range of possible total scores is 5 to 35, with higher scores indicating higher well-being.
2 weeks
Study Arms (2)
Control
SHAM COMPARATORThose receiving no visual feedback because the handheld device monitor will be occluded with black tape (the control group).
Test
EXPERIMENTALThose receiving the ability to visualize their glucose levels via the handheld device (the biofeedback group).
Interventions
Eligibility Criteria
You may not qualify if:
- Below the age of 18 years
- Diagnosis of any known chronic or acute medical disease (e.g., diabetes, cardiovascular disease, respiratory disease, influenza, pneumonia, etc.)
- Diagnosis of any known neurological disease or psychological disorder (e.g., brain lesion, epilepsy, anxiety, eating disorder, mood disorder, sleep disorder, etc.)
- Any implanted electrical medical device (e.g., pacemaker, insulin pump, deep brain stimulator, etc.)
- Suspected or confirmed pregnancy
- Currently breastfeeding
- Use of antibiotics in the three months prior to enrollment
- Any person planning to undergo a Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or high-frequency electrical heat (diathermy) treatment during the duration of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Klick Inc.lead
Study Sites (1)
Klick Inc.
Toronto, Ontario, M4W 3R8, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 29, 2019
First Posted
September 4, 2019
Study Start
July 16, 2019
Primary Completion
November 30, 2019
Study Completion
November 30, 2019
Last Updated
November 17, 2020
Record last verified: 2019-09